Relay Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Relay Therapeutics, Inc. on January 13, 2025. The filing serves as a Regulation FD disclosure regarding the Company's participation in the 43rd Annual J.P. Morgan Healthcare Conference scheduled for the week of January 13, 2025.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces the upcoming conference presentation.
Guidance, Outlook, and Management Commentary
The Company will present slides at the J.P. Morgan Healthcare Conference. These slides are furnished as Exhibit 99.1 and are incorporated by reference. The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Conference Presentation) for specific business updates, as the 8-K text itself contains no operational details.
- Note that the conference presentation materials are not legally "filed" and do not carry the same liability protections as standard SEC filings.
- Verify the date of the conference (week of January 13, 2025) to ensure timely access to the presentation materials.